Combination systemic antifungal therapy for cryptococcosis, candidiasis, and aspergillosis

Journal of Infectious Disease Pharmacotherapy

Volumn 3, Issue 4, 1999, Pages 61-83

  Lewis, R E ^a   Klepser, M E ^a   Pfaller, M A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Amphotericin B; Antagonism; Antifungal; Combination therapy; Fluconazole; Flucytosine; Itraconazole; Pharmacodynamics; Synergy

Indexed keywords

AMPHOTERICIN B; CLOTRIMAZOLE; CYTOCHROME P450; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; QUINOLONE DERIVATIVE; RIFAMPICIN; TERFENADINE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; CANDIDIASIS; CLINICAL TRIAL; CRYPTOCOCCOSIS; DRUG CHOICE; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; TREATMENT PLANNING;

EID: 0032902160     PISSN: 10687777     EISSN: None     Source Type: Journal    
DOI: 10.1300/j100v03n04_04     Document Type: Article

References (86)